Catalyst Biosciences Analysis
| CBIODelisted Stock | USD 0.41 0.02 4.65% |
Catalyst Biosciences is overvalued with Real Value of 0.31 and Hype Value of 0.41. The main objective of Catalyst Biosciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Catalyst Biosciences is worth, separate from its market price. There are two main types of Catalyst Biosciences' stock analysis: fundamental analysis and technical analysis.
The Catalyst Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Catalyst Biosciences is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Catalyst Stock trading window is adjusted to America/New York timezone.
Catalyst |
Catalyst Stock Analysis Notes
About 28.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.53. Some equities with similar Price to Book (P/B) outperform the market in the long run. Catalyst Biosciences has Price/Earnings To Growth (PEG) ratio of 0.02. The entity recorded a loss per share of 1.5. The firm last dividend was issued on the 13th of January 2023. Catalyst Biosciences had 1:15 split on the 13th of February 2017. Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California. Catalyst Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people. For more info on Catalyst Biosciences please contact Nassim Usman at 650 871 0761 or go to https://www.catalystbiosciences.com.Catalyst Biosciences Investment Alerts
| Catalyst Biosciences is not yet fully synchronised with the market data | |
| Catalyst Biosciences has some characteristics of a very speculative penny stock | |
| Catalyst Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 794 K. Net Loss for the year was (8.24 M) with loss before overhead, payroll, taxes, and interest of (64.91 M). | |
| Catalyst Biosciences currently holds about 75.39 M in cash with (33.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company shares are held by company insiders |
Catalyst Biosciences Upcoming and Recent Events
Earnings reports are used by Catalyst Biosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 4th of April 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Catalyst Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.37 M.Catalyst Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Catalyst Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Catalyst Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Catalyst Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nassim Usman over a year ago Disposition of tradable shares by Nassim Usman of Catalyst Biosciences subject to Rule 16b-3 |
Catalyst Biosciences Outstanding Bonds
Catalyst Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Catalyst Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Catalyst bonds can be classified according to their maturity, which is the date when Catalyst Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Catalyst Biosciences Predictive Daily Indicators
Catalyst Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Catalyst Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Catalyst Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Catalyst Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Catalyst shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Catalyst Biosciences. By using and applying Catalyst Stock analysis, traders can create a robust methodology for identifying Catalyst entry and exit points for their positions.
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California. Catalyst Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Catalyst Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |